Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Recurring mutation found in breast, colorectal and ovarian cancers
06-Jul-2007 -
Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. The altered form of AKT1 appears to cause tumor cell proliferation and may play a ...
cell lines
clinical trials
drug development
+8